Functionalizing Extracellular Vesicles for Cancer Treatment
Author Information
Author(s): Gurrieri Elena, D’Agostino Vito Giuseppe
Primary Institution: University of Trento
Hypothesis
Can extracellular vesicles be effectively functionalized to target HER2 for anticancer activity?
Conclusion
Extracellular vesicles can be engineered to target HER2, showing promise for enhanced cancer therapy.
Supporting Evidence
- Extracellular vesicles are stable and can deliver therapeutic agents effectively.
- HER2 is a clinically relevant target for cancer therapy.
- Different strategies exist for functionalizing extracellular vesicles to enhance targeting.
Takeaway
Scientists are figuring out how to make tiny bubbles from cells that can deliver medicine directly to cancer cells, helping to treat the disease better.
Methodology
The review summarizes various strategies for engineering extracellular vesicles to target HER2, including manipulating donor cells and post-isolation modifications.
Limitations
The review does not provide comparative relationships based on the yield of specific EV sub-populations or their stability.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website